Aprea Therapeutics, Inc. revenue breakdown overview

Aprea Therapeutics, Inc. revenue for the last year amounted to 1.50 M USD, the most of which — 1.50 M USD — came from its highest performing source at the moment, Novel Synthetic Lethality-based Cancer Therapeutics, the year earlier bringing 583.23 k USD. The greatest contribution to the revenue figure was made by Sweden — last year it brought Aprea Therapeutics, Inc. 1.50 M USD, and the year before that — 583.23 k USD.